Brkovic Alexandre, Pelletier Martin, Girard Denis, Sirois Martin G
Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, Québec, Canada, H1T 1C8.
J Leukoc Biol. 2007 Apr;81(4):1093-101. doi: 10.1189/jlb.0906580. Epub 2007 Jan 10.
Angiopoietins (Ang1 and Ang2) modulate blood vessel integrity during the angiogenic process through the activation of tyrosine kinase receptor (Tie2). We recently detected Tie2 expression on neutrophils and reported that angiopoietins induce acute proinflammatory events including neutrophil beta2-integrin activation and their adhesion onto endothelial cells. Herein, we investigated the effect of angiopoietins on neutrophil migration and their capacity to modulate CXCL8/IL-8 chemotactic properties. Using a Boyden chamber assay, we observed that Ang1 and Ang2 (up to 10 nM; 60 min) increased the migration of neutrophils, and the maximal effect was achieved at 1 nM (72% and 114% increase, respectively) as compared with untreated cells. Angiopoietins induce a rapid and transient Akt phosphorylation, and pretreatment of neutrophils with PI-3K inhibitors, wortmannin (100 nM) and LY294002 (500 nM), reduced Ang1-mediated neutrophil migration by 100% and 78% and Ang2 chemotactic activity by 100% and 71%, respectively. Treatment of neutrophils with CXCL8/IL-8 (up to 50 nM; 60 min) increased basal neutrophil migration by 257% at its optimal concentration (10 nM), and pretreatment of neutrophils with corresponding PI-3K inhibitors reduced CXCL8/IL-8 (1 nM) chemotactic effect. Pretreatment of neutrophils with Ang1 or Ang2 (10 nM; 15 min) potentiated neutrophil migration induced by CXCL8/IL-8 (1 or 10 nM; 60 min) by 263% and 238% and by 177% and 164%, respectively. Finally, both angiopoietins showed a synergistic effect on the induction of Akt phosphorylation mediated by CXCL8/IL-8. In summary, our data demonstrate that angiopoietins increase neutrophil migration through PI-3K activation and can enhance proinflammatory activities of other cytokines.
血管生成素(血管生成素1和血管生成素2)在血管生成过程中通过激活酪氨酸激酶受体(Tie2)来调节血管完整性。我们最近检测到中性粒细胞上有Tie2表达,并报道血管生成素可诱导急性促炎事件,包括中性粒细胞β2整合素激活及其在内皮细胞上的黏附。在此,我们研究了血管生成素对中性粒细胞迁移的影响及其调节CXCL8/白细胞介素-8趋化特性的能力。使用博伊登小室试验,我们观察到血管生成素1和血管生成素2(高达10 nM;60分钟)可增加中性粒细胞的迁移,与未处理的细胞相比,在1 nM时达到最大效应(分别增加72%和114%)。血管生成素可诱导快速且短暂的Akt磷酸化,用磷脂酰肌醇-3激酶(PI-3K)抑制剂渥曼青霉素(100 nM)和LY294002(500 nM)预处理中性粒细胞,分别使血管生成素1介导的中性粒细胞迁移减少100%和78%,使血管生成素2的趋化活性减少100%和71%。用CXCL8/白细胞介素-8(高达50 nM;60分钟)处理中性粒细胞,在其最佳浓度(10 nM)时可使基础中性粒细胞迁移增加257%,用相应的PI-3K抑制剂预处理中性粒细胞可降低CXCL8/白细胞介素-8(1 nM)的趋化作用。用血管生成素1或血管生成素2(10 nM;15分钟)预处理中性粒细胞,可使由CXCL8/白细胞介素-8(1或10 nM;60分钟)诱导的中性粒细胞迁移分别增强263%和238%,以及177%和164%。最后,两种血管生成素对CXCL8/白细胞介素-8介导的Akt磷酸化诱导均显示出协同作用。总之,我们的数据表明血管生成素通过激活PI-3K增加中性粒细胞迁移,并可增强其他细胞因子的促炎活性。